May 20, 2019
Polycystic Ovarian Syndrome (PCOS) is common, affecting 5 to 15% of women of reproductive age. PCOS can have reproductive, metabolic and psychological implications across the lifespan. This month on COG we talk with Prof Adam Balen about the international evidenced based guideline released in 2018 on the the diagnosis and management of PCOS.
Then in journal club we discuss 4 articles:
Costello, M. F., et al. "Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: assessment and treatment of infertility." (2019): hoy021.
Smithson, David S., Tannys DR Vause, and Anthony P. Cheung. "No. 362-ovulation induction in polycystic ovary syndrome." Journal of Obstetrics and Gynaecology Canada 40.7 (2018): 978-987.
Torres, Pedro J., et al. "Gut microbial diversity in women with polycystic ovary syndrome correlates with hyperandrogenism." The Journal of Clinical Endocrinology & Metabolism 103.4 (2018): 1502-1511.
Varanasi, L. Chitra, et al. "Polycystic ovarian syndrome: prevalence and impact on the wellbeing of Australian women aged 16–29 years." Australian and New Zealand Journal of Obstetrics and Gynaecology 58.2 (2018): 222-233.
Related papers from the International group:
Teede, Helena J., et al. "Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome." Human Reproduction 33.9 (2018): 1602-1618.